Cargando…
Inherited gastrointestinal stromal tumor syndromes: mutations, clinical features, and therapeutic implications
The discovery of underlying molecular genetic abnormalities in gastrointestinal stromal tumors (GISTs) such as activating mutations in the tyrosine kinase genes, KIT and platelet derived growth factor receptor-alpha (PDGFRA), has led to remarkable clinical advances in treatment. Small molecule inhib...
Autores principales: | Postow, Michael A, Robson, Mark E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496697/ https://www.ncbi.nlm.nih.gov/pubmed/23036227 http://dx.doi.org/10.1186/2045-3329-2-16 |
Ejemplares similares
-
Clinical implications of mutational analysis in gastrointestinal stromal tumours
por: Hoeben, A, et al.
Publicado: (2008) -
Current Molecular Profile of Gastrointestinal Stromal Tumors and Systemic Therapeutic Implications
por: Mathias-Machado, Maria Cecilia, et al.
Publicado: (2022) -
Syndromic gastrointestinal stromal tumors
por: Ricci, Riccardo
Publicado: (2016) -
Radiological Features of Metastatic Gastrointestinal Stromal Tumors
por: Patnaik, Sujata, et al.
Publicado: (2012) -
Clinical activity of regorafenib in PDGFRA-mutated gastrointestinal stromal tumor
por: Grellety, Thomas, et al.
Publicado: (2015)